Clinical trial
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With…
NCT00360555 · Sprout Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT00360555 |
|---|---|
| Title | Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder |
| Official title | Best Tolerability: 50mg Twice Daily Versus 100 mg in the Evening Versus 25 mg Twice Daily Versus Placebo in Younger Women in North America |
| Lead sponsor | Sprout Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sexual Dysfunctions, Psychological |
| Intervention type | Drug |
| Interventions | flibanserin, flibanserin 50mg, flibanserin 100mg, placebo |
| Enrollment | 1,584 |
| Start date | Jul 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Aug 4, 2006 |
| Last update posted | Jun 27, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: